Home Formulation Business Markets


Marksans has gained a foothold in the prestigious Australasia markets through its acquisition of Nova Pharmaceuticals Australasia Pty Ltd. in 2005. We are now a prominent distributor to popular retail brands in the region.

Through Nova, Marksans now holds 30 MAs and has become one of the biggest suppliers of generic products here. We continue to grow rapidly and expand into key therapeutic classes. We are leveraging this opportunity and reaching out to the New Zealand pharmaceutical market as well.

  • Ibuprofen 200mg Tablets/Caplets/ Soft gels
  • Aspirin 100, 300mg Tablets
  • Phenylephrine 10mg Tablets
  • Ibuprofen 200mg + Phenylephrine 5mg Caplets
  • Paracetamol 500mg Tablets/Caplets
  • Norfloxacin 400mg Tablets
  • Roxithromycin 150, 300mg Tablets
  • Ranitidine 150, 300mg
  • Quinapril 5, 10, 20mg
  • Analgesics
  • Anti allergy
  • Antibacterial
  • Antibiotic
  • Antiulceratives
  • Hypertension